Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

PaperCitations, authors & open-access status

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 192 citations, 2019 year and hybrid oa status.

192
Citations
2019
Year
hybrid
OA Status

Related on ScholarIQ

Scott Krause
Author
Glioma Diagnosis and Treatment
Topic
Glioma Diagnosis and Treatment
Topic
Ocular Oncology and Treatments
Topic
HER2/EGFR in Cancer Research
Topic
470M+ articles · free account